Pnc Financial Services Group, Inc. Arvinas, Inc. Transaction History

Pnc Financial Services Group, Inc.

$190 Billion
Q1 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 692 shares of ARVN stock, worth $5,044. This represents 0.0% of its overall portfolio holdings.

Number of Shares

692

Previous 4,430 84.38%

Holding current value

$5,044

Previous $84,000 95.24%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$7.02 - $20.5 $26,240 - $76,629	-3,738 Reduced 84.38%	692 $4,000
Q4 2024 Feb 07, 2025	SELL	$17.83 - $28.04 $231 - $364	-13 Reduced 0.29%	4,430 $84,000
Q3 2024 Nov 08, 2024	BUY	$23.66 - $32.73 $40,269 - $55,706	1,702 Added 62.09%	4,443 $109,000
Q2 2024 Aug 09, 2024	BUY	$24.46 - $40.4 $65,014 - $107,383	2,658 Added 3202.41%	2,741 $72,000
Q1 2024 May 10, 2024	BUY	$36.38 - $52.31 $2,510 - $3,609	69 Added 492.86%	83 $3,000
Q4 2023 Feb 09, 2024	SELL	$14.19 - $42.33 $12,941 - $38,604	-912 Reduced 98.49%	14 $0
Q3 2023 Nov 13, 2023	SELL	$19.64 - $28.21 $8,975 - $12,891	-457 Reduced 33.04%	926 $18,000
Q2 2023 Aug 11, 2023	BUY	$21.73 - $31.43 $27,358 - $39,570	1,259 Added 1015.32%	1,383 $34,000
Q1 2023 May 15, 2023	SELL	$26.15 - $37.26 $3,451 - $4,918	-132 Reduced 51.56%	124 $3,000
Q4 2022 Feb 10, 2023	BUY	$32.47 - $57.24 $4,286 - $7,555	132 Added 106.45%	256 $8,000
Q3 2022 Nov 10, 2022	BUY	$41.87 - $57.99 $2,889 - $4,001	69 Added 125.45%	124 $5,000
Q2 2022 Aug 12, 2022	SELL	$36.01 - $74.24 $1,440 - $2,969	-40 Reduced 42.11%	55 $2,000
Q1 2022 May 12, 2022	SELL	$60.27 - $81.57 $2,651 - $3,589	-44 Reduced 31.65%	95 $6,000
Q4 2021 Feb 11, 2022	BUY	$65.85 - $96.21 $658 - $962	10 Added 7.75%	139 $11,000
Q3 2021 Nov 05, 2021	BUY	$73.2 - $107.87 $4,684 - $6,903	64 Added 98.46%	129 $10,000
Q2 2021 Aug 06, 2021	BUY	$60.45 - $84.26 $846 - $1,179	14 Added 27.45%	65 $5,000
Q1 2021 May 07, 2021	SELL	$58.19 - $91.37 $11,463 - $17,999	-197 Reduced 79.44%	51 $3,000
Q2 2020 Aug 07, 2020	BUY	$29.88 - $56.74 $7,410 - $14,071	248 New	248 $8,000

Others Institutions Holding ARVN

# of Institutions

245

Shares Held

62.5M

Call Options Held

2.65M

Put Options Held

1.1M

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $388M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account

Pnc Financial Services Group, Inc. Arvinas, Inc. Transaction History